Literature DB >> 24122714

Unstable genomes elevate transcriptome dynamics.

Joshua B Stevens, Guo Liu, Batoul Y Abdallah, Steven D Horne, Karen J Ye, Steven W Bremer, Christine J Ye, Stephen A Krawetz, Henry H Heng.   

Abstract

The challenge of identifying common expression signatures in cancer is well known, however the reason behind this is largely unclear. Traditionally variation in expression signatures has been attributed to technological problems, however recent evidence suggests that chromosome instability (CIN) and resultant karyotypic heterogeneity may be a large contributing factor. Using a well-defined model of immortalization, we systematically compared the pattern of genome alteration and expression dynamics during somatic evolution. Co-measurement of global gene expression and karyotypic alteration throughout the immortalization process reveals that karyotype changes influence gene expression as major structural and numerical karyotypic alterations result in large gene expression deviation. Replicate samples from stages with stable genomes are more similar to each other than are replicate samples with karyotypic heterogeneity. Karyotypic and gene expression change during immortalization is dynamic as each stage of progression has a unique expression pattern. This was further verified by comparing global expression in two replicates grown in one flask with known karyotypes. Replicates with higher karyotypic instability were found to be less similar than replicates with stable karyotypes. This data illustrates the karyotype, transcriptome, and transcriptome determined pathways are in constant flux during somatic cellular evolution (particularly during the macroevolutionary phase) and this flux is an inextricable feature of CIN and essential for cancer formation. The findings presented here underscore the importance of understanding the evolutionary process of cancer in order to design improved treatment modalities.

Entities:  

Mesh:

Year:  2014        PMID: 24122714      PMCID: PMC4427511          DOI: 10.1002/ijc.28531

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  52 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Analysis of microarray data using Z score transformation.

Authors:  Chris Cheadle; Marquis P Vawter; William J Freed; Kevin G Becker
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

Review 3.  Heterogeneity of cell death.

Authors:  J B Stevens; B Y Abdallah; G Liu; S D Horne; S W Bremer; K J Ye; J Y Huang; M Kurkinen; C J Ye; H H Q Heng
Journal:  Cytogenet Genome Res       Date:  2013-04-03       Impact factor: 1.636

4.  Stochastic cancer progression driven by non-clonal chromosome aberrations.

Authors:  Henry H Q Heng; Joshua B Stevens; Gou Liu; Steven W Bremer; Karen J Ye; Prem-Veer Reddy; Gen Sheng Wu; Y Alan Wang; Michael A Tainsky; Christine J Ye
Journal:  J Cell Physiol       Date:  2006-08       Impact factor: 6.384

5.  Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.

Authors:  Aviva Levine Fridman; Lin Tang; Olga I Kulaeva; Bin Ye; Qunfang Li; Fatimah Nahhas; Paul C Roberts; Susan J Land; Judith Abrams; Michael A Tainsky
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-09       Impact factor: 6.053

6.  Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization.

Authors:  F Z Bischoff; S O Yim; S Pathak; G Grant; M J Siciliano; B C Giovanella; L C Strong; M A Tainsky
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

7.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

8.  Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells.

Authors:  Madhvi B Upender; Jens K Habermann; Lisa M McShane; Edward L Korn; J Carl Barrett; Michael J Difilippantonio; Thomas Ried
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

Review 9.  The multistep nature of cancer.

Authors:  B Vogelstein; K W Kinzler
Journal:  Trends Genet       Date:  1993-04       Impact factor: 11.639

10.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more
  9 in total

1.  Single cell heterogeneity: why unstable genomes are incompatible with average profiles.

Authors:  Batoul Y Abdallah; Steven D Horne; Joshua B Stevens; Guo Liu; Andrew Y Ying; Barbara Vanderhyden; Stephen A Krawetz; Root Gorelick; Henry Hq Heng
Journal:  Cell Cycle       Date:  2013-10-01       Impact factor: 4.534

2.  Of Simple and Complex Genome Rearrangements, Chromothripsis, Chromoanasynthesis, and Chromosome Chaos.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-01-14

3.  Genome plasticity in response to stress in Tetrahymena thermophila: selective and reversible chromosome amplification and paralogous expansion of metallothionein genes.

Authors:  Patricia de Francisco; Ana Martín-González; Aaron P Turkewitz; Juan Carlos Gutiérrez
Journal:  Environ Microbiol       Date:  2018-05-22       Impact factor: 5.491

4.  Stress, genomic adaptation, and the evolutionary trade-off.

Authors:  Steven D Horne; Saroj K Chowdhury; Henry H Q Heng
Journal:  Front Genet       Date:  2014-04-23       Impact factor: 4.599

5.  Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?

Authors:  Henry H Q Heng; Sarah M Regan; Guo Liu; Christine J Ye
Journal:  Mol Cytogenet       Date:  2016-02-13       Impact factor: 2.009

6.  Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.

Authors:  Grazia Palomba; Valentina Doneddu; Antonio Cossu; Panagiotis Paliogiannis; Antonella Manca; Milena Casula; Maria Colombino; Annamaria Lanzillo; Efisio Defraia; Antonio Pazzola; Giovanni Sanna; Carlo Putzu; Salvatore Ortu; Mario Scartozzi; Maria Teresa Ionta; Giovanni Baldino; Giuseppina Sarobba; Francesca Capelli; Tito Sedda; Luciano Virdis; Michela Barca; Giulia Gramignano; Mario Budroni; Francesco Tanda; Giuseppe Palmieri
Journal:  J Transl Med       Date:  2016-10-13       Impact factor: 5.531

7.  Replication catastrophe is responsible for intrinsic PAR glycohydrolase inhibitor-sensitivity in patient-derived ovarian cancer models.

Authors:  Camilla Coulson-Gilmer; Robert D Morgan; Louisa Nelson; Bethany M Barnes; Anthony Tighe; René Wardenaar; Diana C J Spierings; Helene Schlecht; George J Burghel; Floris Foijer; Sudha Desai; Joanne C McGrail; Stephen S Taylor
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16

8.  A Postgenomic Perspective on Molecular Cytogenetics.

Authors:  Henry H Heng; Steven D Horne; Sophia Chaudhry; Sarah M Regan; Guo Liu; Batoul Y Abdallah; Christine J Ye
Journal:  Curr Genomics       Date:  2018-04       Impact factor: 2.236

Review 9.  Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems.

Authors:  Christine J Ye; Sarah Regan; Guo Liu; Sarah Alemara; Henry H Heng
Journal:  Mol Cytogenet       Date:  2018-05-10       Impact factor: 2.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.